Evidence and research in rectal cancer

Radiotherapy and Oncology

Volumn 87, Issue 3, 2008, Pages 449-474

  Valentini, Vincenzo ^a   Beets Tan, Regina ^b   Borras, Josep M ^c   Krivokapić, Zoran ^d   Leer, Jan Willem ^e   Påhlman, Lars ^f   Rödel, Claus ^g   Schmoll, Hans Joachim ^h   Scott, Nigel ⁱ   Velde, Cornelius Van de ^j   Verfaillie, Christine ^k  

^a CATHOLIC UNIVERSITY   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d CLINICAL CENTER OF SERBIA   (Serbia)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g GOETHE UNIVERSITY   (Germany)

^h MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁱ ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k European Society for Therapeutic Radiology and Oncology   (Belgium)

more..

Author keywords

Acute and late toxicity; Adjuvant chemotherapy; Advanced stage; Chemotherapy; Combined modality therapy; Computerized tomography; Concomitant radiochemotherapy; Diagnostic; Early stage; Educational; Endorectal ultrasound; Epidemiology; Follow up; Intermediate stage; Intraoperative radiotherapy; Local excision; Local recurrence; Magnetic resonance imaging; Pathology; Post operative treatment; Pre operative treatment; Quality of life; Radiotherapy; Radiotherapy technique; Randomized clinical trial; Rectal cancer treatment; Scenario of ongoing research; Surgery; Total mesorectal excision

Indexed keywords

ANTINEOPLASTIC AGENT; MOLECULAR MARKER;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER STAGING; DIAGNOSTIC IMAGING; GENETIC MARKER; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; REVIEW;

COMBINED MODALITY THERAPY; HUMANS; RECTAL NEOPLASMS; RISK FACTORS;

EID: 44949291999     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.022     Document Type: Review

References (255)

1. Glimelius B. Introduction to optimal management of rectal cancer. EJC Supplements 65 (2005) 345-347
2. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
3. Cress R.D., Morris C., Ellison G., et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis and race/ethnicity, 1992-2001. Cancer 107 (2006) 1142-1152
4. Fernández E., La Vecchia C., González J.R., et al. Converging patterns of colorectal cancer mortality in Europe. Eur J Cancer 41 (2005) 430-437
5. Berrino F., De Angelis R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of EUROCARE-4 study. Lancet Oncol 8 (2007) 773-783
6. Monnet E., Faivre J., Raymond L., et al. Influence of stage at diagnosis on survival differences for rectal cancer in three european populations. Br J Cancer 81 (1999) 463-468
7. Angell-Andersen E., Tretli S., Coleman M.P., et al. Colorectal cancer survival trends in Norway 1958-97. Eur J Cancer 40 (2004) 734-742
8. Påhlman L., Bohe M., Cedermark B., et al. The Swedish rectal cancer registry. Br J Surg 94 (2007) 1285-1292
9. Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 101 (2002) 403-408
10. Norat T., Bingham S., Ferrari P., et al. Meat, fish hand colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. JNCI 97 (2005) 906-916
11. Park Y., Hunter D.H., Spiegelman D., et al. Dietary fiber intake and risk of colorectal cancer; a pooled analysis of prospective studies. JAMA 294 (2005) 2849-2857
12. Bingham S., Norat T., Moskal A., et al. Is the association with fiber from foods in colorectal cancer confounded by folate inatke?. Cancer Epidemiol Biomarkers Prev 14 (2005) 1552-1556
13. Cho E., Smith-Warner S.A., Spiegelman D., et al. Dairy foods, calcium and colorectal cancer: a pooled analysis of 10 cohort studies. JNCI 96 (2004) 1015-1022
14. Cho E., Smith-Warner S.A., Ritz J., et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140 (2004) 603-613
15. Ferrari P., Jenab M., Norat T., et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the EPIC study. Int J Cancer 121 (2007) 2065-2072
16. Pischon T., Lahman P.H., Boeing H., et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition. JNCI 98 (2006) 920-931
17. In: Vainio H., and Bianchini F. (Eds). IARC handbooks of cancer prevention: weight control and physical activity (2002), IARC Press, Lyon
18. Chan A.T., Giovannucci E.L., Meyerhardt J.A., Schernhammer E.V., Curhan G.C., and Fuchs C.S. Long term use of aspirin and non-steroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294 (2005) 914-923
19. Schotenfeld D., and Winaver S. Cancer of the large intestine. In: Schotenfeld D., and Fraumeni J. (Eds). Cancer epidemiology and prevention (2006), Oxford University Press, New York
20. Browining D., and Martin R.M. Statins and cancer: a systematic review and meta-analysis. Int J Cancer 120 (2006) 833-843
21. Fernandez E., La Vecchia C., Balducci A., et al. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 84 (2001) 722-727
22. Nagy R., Sweet K., and Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 23 (2004) 6445-6470
23. Towler B., Irwig L., Glasziou P., et al. A systematic review of the effects of the screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317 (1998) 559-565
24. Hawk E., and Levin B. Colorectal cancer prevention. J Clin Oncol 23 (2005) 378-391
25. Herrera L., and Brown M.T. Prognostic profile in rectal cancer. Dis Colon Rectum 37 (1994) S1-S5
26. Akasu T., Kondo H., Moriya Y., et al. Endorectal ultrasonography and treatment of early stage rectal cancer. World J Surg 24 (2000) 1061-1068
27. Garcia-Aguilar J., Pollack J., Lee S.H., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 45 (2002) 10-15
28. Gualdi G.F., Casciani E., Guadalaxara A., et al. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum 43 (2000) 338-345
29. Hulsmans F.J., Tio T.L., Fockens P., et al. Assessment of tumor infiltration depth in rectal cancer with transrectal sonography: caution is necessary. Radiology 190 (1994) 715-720 [see comments]
30. Rifkin M.D., Ehrlich S.M., and Marks G. Staging of rectal carcinoma: prospective comparison of endorectal US and CT. Radiology 170 (1989) 319-322
31. Bipat S., Glas A.S., Slors F.J., et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 232 (2004) 773-783
32. Solomon M.J., and McLeod R.S. Endoluminal transrectal ultrasonography: accuracy, reliability, and validity. Dis Colon Rectum 36 (1993) 200-205
33. Marusch F., Koch A., Schmidt U., et al. Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 34 (2002) 385-390
34. Maldjian C., Smith R., Kilger A., et al. Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: a comparison study to rectal endosonography. Abdom Imaging 25 (2000) 75-80
35. Schnall M.D., Furth E.E., Rosato E.F., et al. Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings [see comments]. Radiology 190 (1994) 709-714
36. Zagoria R.J., Schlarb C.A., Ott D.J., et al. Assessment of rectal tumor infiltration utilizing endorectal MR imaging and comparison with endoscopic rectal sonography. J Surg Oncol 64 (1997) 312-317
37. Beets-Tan R.G., Beets G.L., Vliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357 (2001) 497-504
38. Blomqvist L., Rubio C., Holm T., et al. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol 72 (1999) 18-23
39. Gagliardi G., Bayar S., Smith R., et al. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg 137 (2002) 447-451
40. Brown G., Richards C.J., Newcombe R.G., et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211 (1999) 215-222
41. Beets-Tan R.G., and Beets G.L. Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin?. Int J Colorectal Dis 18 (2003) 385-391
42. Bissett I.P., Fernando C.C., Hough D.M., et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 44 (2001) 259-265
43. Blomqvist L., Machado M., Rubio C., et al. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 10 (2000) 653-660
44. Peschaud F., Cuenod C.A., Benoist S., et al. Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Dis Colon Rectum 48 (2005) 1603-1609
45. Lahaye M.J., Engelen S.M., Nelemans P.J., et al. Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 26 (2005) 259-268
46. Beets-Tan R.G., Lettinga T., and Beets G.L. Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome. Eur J Surg Oncol 31 (2005) 681-688
47. MERCURY Study group. Extramural Depth of Tumor Invasion at Thin-Section MR in Patients with Rectal Cancer: Results of the MERCURY Study. Radiology 2007;243:132-139.
48. Wolberink S.V., Beets-Tan R.G., de Haas-Kock D.F., et al. Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Dig Dis 25 (2007) 80-85
49. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 3 (1989) 96-99
50. Will O., Purkayastha S., Chan C., et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7 (2006) 52-60
51. Lahaye M.J., Engelen S.M., Kessels A.G., et al. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 246 (2008) 804-811
52. Heriot A.G., Hicks R.J., Drummond E.G., et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 47 (2004) 451-458
53. Calvo F.A., Domper M., Matute R., et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58 (2004) 528-535
54. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666
55. Guillem J.G., Puig-La Calle Jr. J., Akhurst T., et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 43 (2000) 18-24
56. Amthauer H., Denecke T., Rau B., et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31 (2004) 811-819
57. Chen C.C., Lee R.C., Lin J.K., et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 48 (2005) 722-728
58. de Lussanet Q.G., Backes W.H., Griffioen A.W., et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1309-1315
59. Quirke P. Optimal management of rectal cancer: the role of the pathologist. Eur J Cancer 65 (2005) 349-357
60. Blenkinsopp W.K., Stewart-Brown S., Blesovsky L., Kearney G., and Fielding L.P. Histopathology reporting in large bowel cancer. J Clin Pathol 34 (1981) 509-513
61. Branston L.K., Greening S., Newcombe R.G., et al. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer 38 (2002) 743-744
62. Bull A.D., Biffin A.H., Mella J., et al. Colorectal cancer pathology reporting on regional audit. J Clin Pathol 50 (1997) 138-142
63. Quirke P, Williams GT. The Royal College of Pathologists. Minimum dataset for colorectal cancer histopathology reports. London: The Royal College of Pathologists, 1998. http://www.rcpath.org=ersol;resources/pdf/colorectalcancer.pdf.
64. Maughan N.J., Morris E., Craig S.C., et al. Analysis of Northern and Yorkshire Cancer Registry Data 1995-2001. J Pathol 201 (2003) 18A
65. www.virtualpathology.leeds.ac.uk.
66. Improving Outcomes in Colorectal Cancers, Manual Update. National Institute for Clinical Excellence 2004 (www.nice.org.uk).
67. Goldstein N.S. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years. Am J Surg Pathol 26 (2002) 179-189
68. Swanson R.S., Compton C.C., Stewart A.K., and Bland K.I. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10 (2003) 65-71
69. Quirke P., Durdey P., Dixon M.F., and Williams N.S. Local recurrence of rectal adenocarcinoma is caused by inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 996-999
70. Ng I.O., Luk I.S., Yuen S.T., et al. Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathological features. Cancer 71 (1993) 1972-1976
71. Adam I.J., Mohamdee M.O., Martin I.G., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344 (1994) 707-711
72. De Haas-Koch D.F., Baeten C.G.M.I., Jager J.J., et al. Prognostic significance of radial margins of clearance in rectal carcinoma. Br J Surg 83 (1996) 781-785
73. Wibe A., Rendedal P.R., Svensson E., et al. The Norwegian Rectal Cancer Group. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89 (2002) 327-334
74. Nagtegaal I.D., Marijnen C.A.M., Kranenbarg E.K., Van De Velde C.J.H., and Van Krieken J.H.J.M. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two millimetres is the limit. Am J Surg Pathol 26 (2002) 350-357
75. Adam I.J., Mohamdee M.O., Martin I.G., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344 (1994) 707-711
76. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. The Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 345 (2001) 638-646
77. Marr R., Birbeck K.F., Garvican J., et al. The modern abdomino-perineal excision - the next challenge after total mesorectal excision. Ann Surg 242 (2005) 74-82
78. Medical Research Council. CLASICC Randomised trial of laparoscopic surgery versus conventional open surgery in patients with colorectal cancer. Clinical protocol. http://www.mrc.ac.uk/OurResearch/index.htm.
79. Medical Research Council. Colorectal Cancer Working Party: CR07 Pathology guided treatment in rectal cancer: a randomised trial comparing preoperative radiotherapy and selective postoperative chemoradiotherapy in rectal cancer. Clinical protocol. http://www.mrc.ac.uk/OurResearch/index.htm.
80. Nagtegaal I.D., Van De Velde C.J.H., Van Der Worp E., Kapiteijn E., Quirke P., and Van Krieken J.H.J.M. The pathology review committee for the cooperative clinical investigators of the Dutch colorectal group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20 (2002) 1729-1734
81. Capirci C., Valentini V., Cionini L., et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys (2008) 12-13 [Epub ahead of print]
82. Dworak O., Keilholtz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 (1997) 19-23
83. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathological assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathological correlations. Cancer 73 (1994) 2680-2686
84. Rodel C., Grabenbauer G.G., Papadopoulos T., et al. Apoptosis as a cellular predictor for histopathological response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Rad Oncol Biol Phys 52 (2002) 294-303
85. Sauer R., Becker H., Hoyhenberger W., et al. For the German Rectal Cancer Study Group. Pre-operative versus post-operative chemoradiotherapy for rectal cancer. New Engl J Med 351 (2004) 1731-1740
86. Quirke P. CORE study: capicitabine/oxaliplatin, radiotherapy and excision protocol Study No. C8601. Pathological Technique. 2002, Appendix 7.
87. Heald R.J., and Ryall R.D.H. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 (1986) 1479-1482
88. Grinnell R.S. Distal intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol Obstet 99 (1954) 421-429
89. Heald R.J., Husband E.M., and Ryall R.D.H. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence. Br J Surg 69 (1982) 613-616
90. Scott N., Jackson P., al-Jaberi T., et al. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 82 (1995) 1031-1033
91. Martling A., Cedermark B., Johansson H., et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 89 (2002) 1008-1013
92. Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. CA Cancer J Clin 21 (1971) 361-364
93. Heald R.J. Towards fewer colostomies: the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg 60 (1980) 198-200
94. Wibe A., Møller B., Norstein J., et al. A national strategy change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45 (2002) 857-866
95. Glimelius B., Gronberg H., Jarnhult J., et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42 (2003) 476-492
96. Påhlman L. Optimal management of rectal cancer - is sphincter saving an important end-point?. EJC Supplements 65 (2005) 365-369
97. Gerard J.P., Chapet O., Nemoz C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 15 (2004) 2404-2409
98. Rouanet P., Saint-Aubert B., Lemanski C., et al. Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation. Dis Colon Rectum 45 (2002) 305-315
99. Frigell A., Ottander M., Stenbeck H., and P°ahlman L. Quality of life of patients treated with abdominoperineal resection or anterior resection for rectal carcinoma. Ann Chir Gynaecol 79 (1990) 26-30
100. Holm T., Ljung A., Häggmark T., Jurell G., and Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94 (2007) 232-238
101. Nagtegaall I.D., and Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 26 (2008) 303-312
102. Lavertu S., Schild S.E., Gunderson L.L., et al. Endocavitary radiation therapy for rectal adenocarcinoma. 10 year results. Am J Clin Oncol 26 (2003) 508-512
103. Rauch P., Bey P., Peiffert D., et al. Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 cases. Int J Radiat Oncol Biol Phys 49 (2001) 117-124
104. Gerard J.P., Romestang P., Ardiet J.M., et al. Endocavitary radiation therapy. Sem Radiat Oncol 8 (1998) 13-23
105. Coatmeur O., Truc G., Barillot I., et al. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. Radiother Oncol 70 (2004) 177-182
106. Myerson R.J. Conservative alternatives to radical surgery for favorable rectal cancers. Ann Ital Chir 72 (2001) 605-609
107. Hull T.L., Lavery I.C., and Saxton J.P. Endocavitary irradiation. An option in select patients with rectal cancer. Dis Colon Rectum 37 (1994) 1266-1270
108. Maingon P., Guerif S., Darsouni R., et al. Conservative management of rectal adenocarcinoma by radiotherapy. Int J Radiat Oncol Biol Phys 40 (1998) 1077-1085
109. Gerard J.P., Ayzac L., Coquard R., et al. Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique. Int J Radiat Oncol Biol Phys 34 (1996) 775-783
110. Minsky B.D., Mies C., Rich T.A., et al. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 17 (1989) 311-318
111. Neary P., Makin G.B., White T.J., et al. Transanal endoscopic microsurgery: a viable operative alternative in selected patients with rectal lesions. Ann Surg Oncol 10 (2003) 1106-1111
112. Willett C.G. Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy. Semin Radiat Oncol 8 (1998) 24-29
113. Kim C.J., Yeatman T.J., Coppola D., et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234 (2001) 352-358
114. Bonnen M., Crane C., Vauthey J.N., et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60 (2004) 1098-1105
115. Ruo L., Guillem J.G., Minsky B.D., et al. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorecal Dis 17 (2002) 54-58
116. Wagman R.T., and Minsky B.D. Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Huntingt) 15 (2001) 513-519, 524
117. Benson R., Wong C.S., Cummings B.J., et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1309-1316
118. Rosenthal S.A., Yeung R.S., Weese J.L., et al. Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I-II trial. Cancer 69 (1992) 335-341
119. Valentini V., Morganti A.G., De-Santis M., et al. Local excision and external beam radiotherapy in early rectal cancer. Int J Radiat Oncol Biol Phys 35 (1996) 759-764
120. Fortunato L., Ahmad N.R., Yeung R.S., et al. Long-term followup of local excision and radiation therapy for invasive rectal cancer. Dis Colon Rectum 38 (1995) 1193-1199
121. Mendenhall W.M., Rout W.R., Vauthey J.N., Haigh L.S., Zlotecki R.A., Copeland E.M., et al. Conservative treatment of rectal adenocarcinoma with endocavitary irradiation or wide local excision and postoperative irradiation. J Clin Oncol 15 (1997) 3241-3248
122. Chakravarti A., Compton C.C., Shellito P.C., et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 230 (1999) 49-54
123. Rödel C, Valentini V, Minsky B, Rectal cancer. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. "nd Edition. Philadelphia: Elsevier Churchill Livingstone; 2007. p. 1113-1143.
124. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
125. Camma C., Giunta M., Fiorica F., et al. Preoperative radiotherapy for resectable rectal cancer: a metaanalysis. JAMA 284 (2000) 1008-1015
126. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358: 1291-304.
127. Munro A.J., and Bentley A. Adjuvant radiotherapy in operable rectal cancer: a systematic review. Sem Colon Rectal Surg 13 (2002) 31-42
128. Sebag-Montfiore D., Steele R., Quike P., et al. Short-course preoperative radiotherapy results improves outcome when compared with highly selective postoperative radiochemotherapy. Preliminary results of the MRC CR07 randomised trial. Radiother Oncol 819 (2006) s19 [abstract]
129. Peeters K.C., Marijnen C.A., Nagtegaal I.D., et al. Dutch Colorectal Cancer Group The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
130. Eriksen M.T., Wibe A., Haffner J., and Wiig J.N. Norwegian Rectal Cancer Group. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50 (2007) 156-167
131. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
132. Bosset J.F., Collette L., Calais G., et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
133. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
134. Collette L., Bosset J.F., den Dulk M., et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25 (2007) 4379-4386
135. QUASAR Collaborative Group. Gray R, Barnwell J, McConkey C et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007;370:2020-9.
136. Schmoll H.J., Cartwright T., Tabernero J., et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol 25 (2007) 102-109
137. Onaitis M.W., Noone R.B., Fields R., et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 8 (2001) 801-806
138. Pucciarelli S., Toppan P., Friso M.L., et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 47 (2004) 1798-1807
139. Valentini V., Coco C., Cellini N., et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 51 (2001) 371-383
140. Francois Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17 (1999) 2396
141. Wagman R., Minsky B.D., Cohen A.M., Guillem J.G., and Paty P.P. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 42 (1998) 51-57
142. Vecchio F.M., Valentini V., Minsky B.D., et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 752-760
143. Willett C.G., Boucher Y., di Tomaso E., et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10 (2004) 145-147
144. Luna-Perez P., Segura J., Alvarado I., et al. Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol 7 (2000) 727-731
145. Villafranca E., Okruzhnov Y., Dominguez M.A., et al. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 19 (2001) 1779-1786
146. Esposito G., Pucciarelli S., Alaggio R., et al. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol 8 (2001) 311-318
147. Saw R.P., Morgan M., Koorey D., et al. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum 46 (2003) 192-202
148. Kandioler D., Zwrtek R., Ludwig C., et al. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 235 (2002) 493-498
149. Rodel C., Grabenbauer G.G., Papadopoulos T., et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 294-303
150. Adell G., Zhang H., Jansson A., et al. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 50 (2001) 659-663
151. Balslev I., Pedersen M., Teglbjaerg P.S., et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer 58 (1986) 22-28
152. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312:1465-72.
153. Arnaud J.P., Nordlinger B., Bosset J.F., et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 84 (1997) 352-357
154. Fisher B., Wolmark N., Rockette H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80 (1988) 21-29
155. Bosset J.F., Horiot J.C., Hamers H.P., et al. Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 61 (2001) 7-13
156. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
157. O'Connell M.J., Martenson J.A., Weiand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
158. Smalley S.R., Benedetti J.K., Williamson S.K., et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24 (2006) 3542-3547
159. Lee J.H., Lee J.H., Ahn J.H., et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 20 (2002) 1751-1758
160. Cafiero F., Gipponi M., Peressini A., et al. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-Fu and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol 75 (2000) 80-88
161. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22 (2004) 1785-1796
162. Minsky B.D., Cohen A.M., Kemeny N., et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 10 (1992) 1218-1224
163. Tveit K.M., Guldvog I., Hagen S., et al. Randomized controlled trial of postoperative radiotherapy and short-term timescheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84 (1997) 1130-1135
164. Fountzilas G., Zisiadis A., Dafni U., et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 10 (1999) 671-676
165. Pahlman L., and Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 211 (1990) 187-195
166. Braendengen M., Tveit K.M., and Berglund A. A randomized phase III study (LARCS) comparing preoperative radiotherapy alone vs chemoradiotherapy
167. Myerson R.J., Valentini V., Birnbaum E.H., et al. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Int J Radiat Oncol Biol Phys 50 (2001) 1299-1308
168. Rodel C., Grabenbauer G.G., Schick C., Papadopoulos T., Hohenberger W., and Sauer R. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol 176 (2000) 161-167
169. Pfeiffer P. High-dose radiotherapy and concurrent UFT plus 1-leucovorin in locally advanced rectal cancer: a phase I trial. Acta Oncol 44 (2005) 224-229
170. Law W.L., Chu K.W., and Choi H.K. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 190 (2000) 78-83
171. Reerink O., Verschueren R.C., Szabo B.G., Hospers G.A., and Mulder N.H. A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 39 (2003) 192-195
172. Gunderson L.L., Willett C.G., Harrison L.B., and Calvo F.A. Intraoperative irradiations (1999), Human Press, Philadelphia
173. Strassmann G., Walter S., Kolotas C., et al. Reconstruction and navigation system for intraoperative brachytherapy using the flab technique for colorectal tumor bed irradiation. Int J Radiat Oncol Biol Phys 47 (2000) 1323-1329
174. Alektiar K.M., Zelefsky M.J., Paty P.B., et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 48 (2000) 219-226
175. Nuyttens J.J., Kolkman-Deurloo I.K., Vermaas M., et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 58 (2004) 106-112
176. Harrison L.B., Minsky B.D., Enker W.E., et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys 42 (1998) 325-330 (146)
177. Gunderson L.L., Nelson H., Martenson J.A., et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. Int J Radiat Oncol Biol Phys 37 (1997) 601-614
178. Nakfoor B.M., Willett C.G., Shellito P.C., Kaufman D.S., and Daly W.J. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. Ann Surg 228 (1998) 194-200
179. Huber F.T., Stepan R., Zimmermann F., Fink U., Molls M., and Siewert J.R. Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy. Dis Colon Rectum 39 (1996) 774-779
180. Kallinowski F., Eble M.J., Buhr H.J., Wannenmacher M., and Herfarth C. Intraoperative radiotherapy for primary and recurrent rectal cancer. Eur J Surg Oncol 21 (1995) 191-194
181. Mannaerts G.H., Rutten H.J., Martijn H., Hanssens P.E., and Wiggers T. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 44 (2001) 1749-1758
182. Gagliardi G., Hawley P.R., Hershman M.J., et al. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 82 (1995) 1401-1405
183. Bagatzounis A., Kolbl O., Muller G., et al. The locoregional recurrence of rectal carcinoma. A computed tomographic analysis and a target volume concept for adjuvant radiotherapy. Strahlenther Onkol 173 (1997) 68-75
184. Suzuki K., Gunderson L.L., Devine R.M., et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 75 (1995) 939-952
185. Lindel K., Willett C.G., Shellito P.C., et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 58 (2001) 83-87
186. Wiig J.N., Tveit K.M., Poulsen J.P., et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 62 (2002) 207-213
187. Mohiuddin M., Marks G., and Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 95 (2002) 1144-1150
188. Valentini V., Morganti A.G., Gambacorta M.A., et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase ii study. Int J Radiat Oncol Biol Phys 64 (2006) 1129-1139
189. Kim H.K., Jessup J.M., Beard C.J., et al. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 38 (1997) 777-783
190. Gunderson L.L., and Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34 (1974) 1278-1292
191. Hruby G., Barton M., and Miles S. Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer; implications for radiotherapy field design. Int J Radiat Oncol Biol Phys 55 (2003) 138-143
192. Roels S., Duthoy W., Haustermans K., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1129-1142
193. Tait D.M., Nahum A.E., Meyer L.C., et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol 42 (1997) 121-136
194. Koelbl O., Vordermark D., and Flentje M. The relationship between belly board position and patient anatomy and its influence on dose-volume histogram of small bowel for postoperative radiotherapy of rectal cancer. Radiother Oncol 67 (2003) 345-349
195. Duthoy W., De Gersem W., Vergote K., et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 60 (2004) 794-806
196. Patel S., Vuong T., Ballivy O., et al. Phase II trial of pelvic intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy for patients with rectal cancer. Int J Radiat Oncol Biol Phys 60 (2004) s424-s425
197. Withers H.R., Peters L.J., and Taylor J.M. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31 (1995) 353-359
198. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24 (2006) 650-655
199. Marijnen C.A.M., Nagtegaal I.D., Kapiteijn E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1311-1320
200. De Neve W., Martijn H., Lybeert M.M., et al. Incompletely resected rectum, rectosigmoid, or sigmoid carcinoma: Results of postoperative radiotherapy and prognostic factors. Int J Radiat Oncol Biol Phys 21 (1991) 1297-1302
201. Minsky B.D., Conti J.A., Huang Y., et al. The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13 (1995) 1409-1416
202. Gunderson L.L., Russell A.H., Llewellyn H.J., et al. Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 11 (1985) 1379-1393
203. Dahlberg M., Glimelius B., Graf W., and P°ahlman L. Preoperative irradiation for rectal cancer affects the functional results after colorectal anastomosis - results from the Swedish Rectal Cancer Trial. Dis Colon Rectum 41 (1998) 543-551
204. Marijnen C.A., Van De Velde C.J., Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23 (2005) 1847-1858
205. Kollmorgen C.F., Meagher A.P., Pemberton J.H., et al. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 220 (1994) 76-81
206. Lazorthes F., Fages P., Chiotasso P., Lemozy J., and Bloom E. Resection of the rectum with construction of a colonic reservoir and coloanal anastomosis for carcinoma of the rectum. Br J Surg 73 (1986) 136-138
207. Hallböök O., P°ahlman L., Krog M., et al. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg 224 (1996) 58-65
208. Hamel C.T., Metzger J., Curti G., et al. Ileocecal reservoir reconstruction after total mesorectal excision: functional results of the long-term follow-up. Int J Colorectal Dis 19 (2004) 574-579
209. Z'graggen K., Maurer C.A., Birrer S., et al. A new surgical concept for rectal replacement after low anterior resection: transverse coloplasty pouch. Ann Surg 234 (2001) 780-785
210. Cavina E., Seccia M., Evangelista G., et al. Perineal colostomy and electrostimulated gracilis neosphincter after abdomino-perineal resection of the colon and anorectum: a surgical experience and follow-up study in 47 cases. Int J Colorectal Dis 5 (1990) 6-11
211. Baeten C.G.M., Konsten J., Spaans F., et al. Dynamic graciloplasty for treatment of faecal incontinence. Lancet 338 (1991) 1163-1165
212. Williams N.S., Patel J., George B.D., Hallan R.I., and Watkins E.S. Development of an electrically stimulated neo-anal sphincter. Lancet 338 (1991) 1166-1169
213. Rosen H.R., Urbarz C., Novi G., et al. Long-term results of modified graciloplasty for sphincter replacement after rectal excision. Colorectal Dis 4 (2002) 266-269
214. Dini D., Venturini M., Forno G., et al. Irrigation for colostomized cancer patients: a rational approach. Int J Colorect Dis 6 (1991) 9-11
215. Miller R.C., Sargent D.J., Martenson J.A., et al. Int J Radiat Oncol Biol Phys 54 (2002) 409-413
216. Willett C.G., Tepper J.E., Kaufman D.S., et al. Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol 15 (1992) 371-375
217. Birgisson H., Påhlman L., Gunnarsson U., et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23 (2005) 6126-6131
218. Hendren S.K., et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 242 (2005) 212-223
219. Heriot A.G., Tekkis P.P., Fazio V.W., Neary P., and Lavery I.C. Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg 242 (2005) 502-510
220. Junginger T., Kneist W., and Heintz A. Influence of identification and preservation of pelvic autonomic nerves in rectal cancer surgery on bladder dysfunction after total mesorectal excision. Dis Colon Rectum 46 (2003) 621-628
221. Kim N.K., et al. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 45 (2002) 1178-1185
222. Moriya Y. Function preservation in rectal cancer surgery. Int J Clin Oncol 11 (2006) 339-343
223. Pollack J., et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93 (2006) 1519-1525
224. Bonnel C., et al. Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 45 (2002) 934-939
225. Maas C.P., Moriya Y., Steup W.H., Klein K.E., and van de Velde C.J. A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. Eur J Surg Oncol 26 (2000) 751-757
226. Prabhudesai A.G., Cornes P., Glees J.P., and Kumar D. Long-term morbidity following short-course, pre-operative radiotherapy and total mesorectal excision for rectal cancer. Surgeon 3 (2005) 347-351
227. Morgentaler A. Male impotence. Lancet 354 (1999) 1713-1718
228. Havenga K., Maas C.P., DeRuiter M.C., et al. Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer. Semin Surg Oncol 18 (2000) 235-243
229. Rees P.M., Fowler C.J., and Maas C.P. Sexual function in men and women with neurological disorders. Lancet 369 (2007) 512-525
230. Santangelo M.L., Romano G., and Sassaroli C. Sexual function after resection for rectal cancer. Am J Surg 154 (1987) 502-504
231. Schmidt C., et al. Quality of life and sexuality after surgery for rectal cancer - a follow-up study. Zentralbl Chir 130 (2005) 393-399
232. da Silva G.M., et al. The efficacy of a nerve stimulator (CaverMap) to enhance autonomic nerve identification and confirm nerve preservation during total mesorectal excision. Dis Colon Rectum 47 (2004) 2032-2038
233. Rosen M., Chan L., Beart R.W., Vukasin P., and Anthone G. Follow-up of colorectal cancer. A meta-analysis. Dis Colon Rectum 41 (1998) 1116-1126
234. Kievit J., and Bruinvels D.J. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer 31A (1995) 1222-1225
235. Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 38 (2002) 986-999
236. Mella J., Radcliffe A.G., Datta S.N., Steele R.J.C., Biffin A., and Stamatakis J.D. Surgeons' follow-up practice after resection of colorectal cancer. Ann Roy Coll Surg 79 (1997) 206-209
237. Jeffery GM., Hickey BE., and Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane Review). The Cochrane Library, Issue 4 (2002), Update Software, Oxford
238. Renehan A.G., Egger M., Saunders M.P., and O'Dwyer S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324 (2002) 813-821
239. Secco G.B., Fardelli R., Gianquino D., Bonfante P., Baldi E., Ravera G., et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective randomised and controlled trial. EJSO 28 (2002) 418-423
240. Pietra N., Sarli L., Costi R., Ouchemi C., Grattarola M., and Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 41 (1998) 1127-1133
241. Smith T.J., and Bear H.D. Standard follow-up of colorectal cancer patients: finally we can make practice guidelines based on evidence. Gastroenterology 114 (1998) 211-213
242. Cali R.L., Pitsch R.M., Thorson A.G., et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36 (1993) 388-393
243. Anthony T., Simmang C., Hyman N., Buie D., Kim D., Cataldo P., et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 47 (2004) 807-817
244. Figueredo A., Rumble R.B., Maroun J., Earle C.C., Cummings B., McLeod R., et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 3 (2003) 26
245. Worthington T.R., Wilson T., and Padbury R. Case for postoperative surveillance following colorectal cancer resection. ANZ J Surg 74 (2004) 43-45
246. Lezoche E., Guerrieri M., Paganini A.M., et al. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. World J Surg 26 (2002) 1170-1174
247. Habr-Gama A., Perez R.O., Proscurshim I., et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10 (2006) 1319-1328
248. Eriksen M.T., Wibe A., Haffner J., et al. Norwegian Rectal Cancer Group. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50 (2007) 156-167
249. Radu C., Berglund Å., Påhlman L., et al. Short-course preoperative radiotherapy with delayed surgery in rectal cancer - A retrospective study. Radiother Oncol 87 (2008) 343-349
250. Baumann M., and Krause M. Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72 (2004) 257-266
251. Giralt J., de las Heras M., Cerezo L., et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiother Oncol 74 (2005) 101-108
252. Czito B.G., Bendell J.C., Willett C.G., et al. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. Int J Radiat Oncol Biol Phys 68 (2007) 472-478
253. Hofheinz R.D., Horisberger K., Woernle C., et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1384-1390
254. Machiels J.P., Sempoux C., Scalliet P., et al. Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol 18 (2007) 738-744
255. Rodel C., Arnold D., Hipp M., et al. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys (2007) [Epub ahead of print]